NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 121 filers reported holding NUVATION BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,538,748 | +8.4% | 5,854,860 | 0.0% | 0.22% | +3.7% |
| Q1 2023 | $9,719,068 | -13.5% | 5,854,860 | 0.0% | 0.22% | -6.9% |
| Q4 2022 | $11,241,331 | +1943.9% | 5,854,860 | +2286.2% | 0.23% | +2018.2% |
| Q3 2022 | $550,000 | -97.1% | 245,360 | -93.1% | 0.01% | -97.4% |
| Q1 2022 | $18,816,000 | -38.1% | 3,577,233 | 0.0% | 0.42% | -34.0% |
| Q4 2021 | $30,406,000 | -14.5% | 3,577,233 | 0.0% | 0.64% | -8.1% |
| Q3 2021 | $35,558,000 | +6.8% | 3,577,233 | 0.0% | 0.69% | +17.2% |
| Q2 2021 | $33,304,000 | +6.2% | 3,577,233 | +19.2% | 0.59% | -10.2% |
| Q1 2021 | $31,350,000 | – | 3,000,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 22,957,340 | $195,137,000 | 27.59% |
| Aisling Capital Management LP | 2,541,009 | $21,599,000 | 7.62% |
| EDBI Pte Ltd | 1,270,504 | $10,799,000 | 5.87% |
| EcoR1 Capital, LLC | 13,896,543 | $118,121,000 | 3.76% |
| Ally Bridge Group (NY) LLC | 1,197,152 | $10,176,000 | 3.56% |
| Boxer Capital, LLC | 4,341,009 | $36,899,000 | 1.43% |
| Avidity Partners Management LP | 7,382,488 | $62,751,000 | 1.33% |
| Baupost Group | 8,623,021 | $72,957,000 | 0.72% |
| Abrams Capital Management | 3,811,513 | $32,398,000 | 0.71% |
| Redmile Group, LLC | 3,671,009 | $31,204,000 | 0.71% |